Our mission is to provide high-quality industrial IT services and take part in Research and Development projects, with a special emphasis on continuous
progress while staying a trusted partner for clients all across Europe.
Our mission is to provide high-quality industrial IT services and take part in Research and Development projects, with a special emphasis on continuous
progress while staying a trusted partner for clients all across Europe.
At Egnosis, all little gears are in motion. We are an open-minded community that is built on quality and high standards. If you are planning a long-term future in a viable city with a reliable team, then you are in the right place.
At Egnosis all little gears are in motion. If you are planning a long-term future in a viable city with a reliable team, then you are in the right place.
Egnosis has recognized the inherent challenge in research, its need and its benefits. In 2019, we entered the EU-funded Horizon Research Programme and have stood strong among the best researchers in Western Europe in bioinformatics and systems medicine.
Egnosis participates in the EU-funded Horizon Research Programme and have stood strong among the best researchers in Western Europe in bioinformatics and systems medicine.
Clean code, straight talk.
Software development is a high value-added and largely creative field which requires a meticulous engineer-like approach. It calls for persistence, attention, patience, and a constant desire to learn. And that’s just the basics. On top of these comes the structured mindset, the daily practice of diligence, the focus on efficiency, technical project planning, monitoring, and then analysis.
Within the framework of this service, we build on a market validated methodology and workflow: the “Software Development Lifecycle”.
Read moreThe mobile application development flow used by Egnosis has been derived from industrial software development, taking into account the characteristics of devices and user behaviours.
Read moreA technology migration is an extremely complex task, as in addition to the knowledge of the business domain, software architects must be able to understand the operation.
Read moreResearch & Development
Egnosis has recognised the inherent challenge in research, as well as the need for it and its benefits. In 2019, we have entered the EU funded Horizon Research Programme and have stood strong among the best researchers in Western Europe. We see it as our mission to encourage expatriate researchers to return home and to engage them in bioinformatics projects with competitive salaries.
We aim to be a role model for IT companies, encouraging a shift from working on outsourced projects to research and product development. At the same time, we are committed to retaining intellectual property rights through research and thereby creating value, especially for bioinformatics and healthcare.
An all-in-one platform to RUN, DEVELOP & PUBLISH federated & privacy-preserving machine learning algorithms.
We envision a future in which doctors can easily and safely store, access, and manage primary medical patient data.
Read moreA virtual, connected community in drug repurposing to foster collaboration, networking and knowledge transfer.
REPO4EU is the vision of a group of long-standing collaborators in innovative drug repurposing to build a comprehensive European/global platform for validated precision drug repurposing open to stakeholders for information, multimedia training, matchmaking, and cooperation.
Read moreOptimising data curation & publishing processes for unstructured medical data by orchestrating complementary AI technologies into a virtual assistant. AIDAVA can play a major role in preventive care (longitudinal health record of cardiovascular patients at risk of sudden cardiac arrest) and in making the treatments more effective (breast cancer registries federated across hospitals).
Read moreIn the EU, colorectal cancer affects 1 in 35 women and 1 in 23 men. Timely CRC identification is crucial: we aim to increase colonoscopy necessity prediction specificity by over 20% using metagenomic microbiomes.
Read moredAIbetes aims to achieve personalized prediction of treatment outcomes for patients with type 2 diabetes, a prevalent condition that affects 1 in 10 adults globally. The partners will unify global data from 800,000 type 2 diabetes patients to train prognostic virtual twin models.
Read moreIn-House
Companies are changing continuously, organic growth and acquisitions being important drivers. That is why it is imperative to work with a convenient project management solution in every project phase.
Read moreOur Flowtrack product is a real-time production tracking system for small and medium-sized enterprises, production units and production lines.
Read moreLast week, on October 30, Egnosis participated in the Drug Repurposing Cluster meeting in Brussels hosted by the European Health and Digital Executive Agency (HaDEA). This gathering served as a valuable touchpoint for Horizon Europe-funded projects REPO4EU and REMEDi4ALL, providing opportunities to showcase recent advancements and foster collaboration. EU project officer Monica Ensini commenced the tight agenda. In her warm, welcoming address, she outlined the significance and priority of the two named projects, as the expectations placed upon them are extremely high. Further, the coordinators—Harald H.H.W. Schmidt from REPO4EU, Anton Ussi and Donald Lo from REMEDi4ALL—presented the projects’ results so... Continue reading Home
Read moreEgnosis earned first place in the Research and Development, and High-Tech category for small businesses for another consecutive year. This achievement highlights our commitment to quality, innovation, and excellence in the high-tech industry. The annual Awards Gala, hosted by the Covasna County Chamber of Commerce and Industry, celebrated the region’s most distinguished companies on October 24, 2024, at Kolcza Restaurant. Within the gala, performing companies from Covasna County were awarded in all major fields of industry in Romania. For Egnosis, this recognition reflects more than competitive success. It is a testament to our commitment to fostering a high-performing, forward-looking community... Continue reading Home
Read moreMunich has not only been whizzing about the EURO2024 championship but also systems medicine, as last week hosted RExPO24, the 3rd International Conference on Systems Medicine, AI & Drug Repurposing, uniting experts and participants to form a robust drug-repurposing community. The Egnosis delegation was also present at the event. Besides, our colleague Balázs Orbán delivered a captivating presentation on the potential of precision drug repurposing through the RePo4EU unified platform. The RePo4EU unified platform Within REPO4EU, the Horizon Europe-funded research project, we aim to establish a first-in-class coherent and innovative web-based platform for safe and efficient drug repurposing for all... Continue reading Home
Read moreIn a significant stride towards advancing precision medicine, a consortium coordinated by Prof. Dr. Jan Baumbach from the University of Hamburg (Germany), with 13 partners from seven countries, including Egnosis, has been awarded a prestigious Horizon Europe grant to develop a cutting-edge federated health data infrastructure. The project named “dAIbetes” is revolutionizing Type 2 diabetes care. It focuses on leveraging virtual twins as predictive tools in personalized disease management, targeting treatment outcomes in type2 diabetes. The project started on 01 January 2024. To develop virtual twins as prognostic tools for precision medicine the partners of dAIbetes will integrate extensive datasets... Continue reading Home
Read more“Fast and smooth communication and software development on a constantly high-quality level are key criteria for us. Based on our positive experience, we will expand our cooperation in the future, and we are looking forward to working and developing complex state-of-the-art software with our colleagues at Egnosis”.
Carsten Schmidt
Klusa – Former Division Manager, OPUS GmbH Germany
“We have worked together on a project of The National Institute of Occupational Health in Norway. Egnosis, as part of the international project team, was responsible for the backend work in addition to an Angular-based frontend module. The Egnosis team is skilled problem-solvers and always knows which questions to ask to get to the bottom of things. They met every deadline that was set, and all deliveries were of the highest standard.”
Espen Bjaarstad
CEO – Netlab AS, Norway
“TEAM has been working with Egnosis since 2017. Throughout our cooperation, they have been demonstrating their expertise in several projects, particularly in orchestrating complex migration projects. We appreciate the flexible and cooperative partner that Egnosis proved itself to be.”
Heike Käferle
Managing Director - TEAM GmbH Germany
“The Gnome Design Ltd. is providing continuously a professional IT solution in our EU research projects. The reaction time is fast, the finalized job is accurate. The communication with the Gnome team is straightforward. They are always helpful and they offer a pragmatic and cost effective solution. Through our partnership we have experienced Gnome Design Ltd. as a reliable and serious partner and we believe in our continuous collaboration on existing and new requirements and projects.”
Ameli Schwalber
CEO, concentris Research Management GmbH
International Business
Local Business
Associations and Business Groups
Research Universities
Research Institutes
"What would one say if one is more than happy to have an outstanding and trustworthy partner like Egnosis? They’ve never disappointed us, but more than that, they’ve also been consistently ahead in the field. Maybe exactly this.”
Prof. Dr. Jan Baumbach
FeatureCloud Project Coordinator, Director of the Institute for Computational Systems Biology University of Hamburg
"A highly professional and fast delivering team on complex web-based programming needs. We worked nicely in the Horizon 2020 project REPO-TRIAL and will now expand this in the European platform project REPO4EU.”
Prof. Dr. Med. Harald H.H.W. Schmidt
Maastricht University The Netherlands
Egnosis all rights reserved © 2024